P832: PROSPECTIVE REAL-WORLD EVALUATION OF THE PREVALENCE OF T(11;14) IN MULTIPLE MYELOMA: THIRD INTERIM ANALYSIS FROM THE MEDICI STUDY

• Maria Gavriatopoulou,
• Andrew Spencer,
• Daniel Coriu,
• Fernando Escalante Barrigón,
• Roman Hájek,
• Fernanda Seguro,
• Norma C. Gutiérrez,
• Sandra Basic Kinda,
• Massimo Offidani,
• Dorotea Beatriz Eugenia Fantl,
• Rosane Bittencourt,
• Anna Lysén,
• Vladimir Maisnar,
• Elham Askari,
• Joaquín Martinez-Lopez,
• Olivia Hughes,
• Rebekah Taylor,
• Kristin Lehn,
• Roby Joehanes,
• Jeremy Ross,
• Carlos Hader

Affiliations

Maria Gavriatopoulou

1 Alexandra General Hospital, School of Medicine, National and Kapodistrian University of Athens, Department of Clinical Therapeutics, Athens, Greece

Andrew Spencer

2 Alfred Health-Monash University, Melbourne, Australia

Daniel Coriu

3 Carol Davila University of Medicine and Pharmacy, Fundeni Clinical Institute, Bucharest, Romania

Fernando Escalante Barrigón

4 Complejo Asistencial Universitario de León, León, Spain

Roman Hájek

5 University Hospital Ostrava and Department of Hematooncology, Faculty of Medicine, University of Ostrava, Department of Hematooncology, Ostrava, Czech Republic

Fernanda Seguro

6 Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, (HCFMUSP), São Paulo, Brazil

Norma C. Gutiérrez

8 Hospital Universitario de Salamanca, Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain

Sandra Basic Kinda

9 University Hospital Centre Zagreb, Zagreb, Croatia

Massimo Offidani

10 AOU delle Marche, Ancona, Italy

Dorotea Beatriz Eugenia Fantl

11 Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

Rosane Bittencourt

12 Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil

Anna Lysén

13 Oslo Myeloma Center, Oslo University Hospital, Department of Hematology, Oslo, Norway

Vladimir Maisnar

15 University Hospital and Faculty of Medicine Hradec Kralove, Charles University, Hradec Kralove, Czech Republic

Elham Askari

16 Hospital Universitario Fundación Jiménez Díaz, IIS-FJD, Department of Hematology, Madrid, Spain

Joaquín Martinez-Lopez

17 Hospital Universitario 12 de Octubre, Department of Hematology, Madrid, Spain

Olivia Hughes

18 ICON plc, Blue Bell, Pennsylvania, United States

Rebekah Taylor

19 AbbVie Inc, North Chicago, Illinois, United States

Kristin Lehn

19 AbbVie Inc, North Chicago, Illinois, United States

Roby Joehanes

19 AbbVie Inc, North Chicago, Illinois, United States

Jeremy Ross

19 AbbVie Inc, North Chicago, Illinois, United States

Carlos Hader

19 AbbVie Inc, North Chicago, Illinois, United States